Perrigo continues to make headlines, having recently settled a lawsuit with investors for $97 million over allegations of misleading statements intended to fend off a potential $29 billion takeover. This settlement further underscores the dynamic nature of Perrigo’s operations in the pharmaceutical sector.
- America
- And More
- Arizona
- Brand Stories
- Business
- California News
- Florida
- Florida News
- Industry News
- International
- Investigates
- New York News
- Opinion
- Pennsylvania
- Premium
- Tallahassee
- The People's Voice
- U.S. News
- USA Herald
